期刊
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
卷 26, 期 8, 页码 899-909出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/10837450.2021.1955927
关键词
Chitosan nanoparticles (CS NPs); ionic liquid (IL); pH-responsive; 4-boron-L-phenylalanine (BPA); glioblastoma (GB); mitoxantrone (MTO)
In this study, novel pH-responsive boron phenylalanine (BPA) targeted nanoparticles were introduced for selective delivery of mitoxantrone (MTO) to U87MG glioma cells. The nanoparticles showed a lower IC50 and better cellular uptake compared to non-targeted nanoparticles, indicating promising potential for cancer treatment.
Nanotechnology has revolutionized drug delivery in cancer treatment. In this study, novel efficient pH-responsive boron phenylalanine (BPA) targeted nanoparticles (NPs) based on ionic liquid modified chitosan have been introduced for selective mitoxantrone (MTO) delivery to the U87MG glioma cells. Urocanic acid (UA) and imidazolium (Im) based ionic liquids were used for structural modification simultaneously. The NPs were prepared by ionic gelation and fully characterized; the pH-responding and swelling index of NPs were studied carefully. The drug release was studied at a pH of 5.5 in comparison to the neutral state. Also, the cytotoxicity of loaded NPs was evaluated on U87MG glial cells, and cellular uptake was studied. The NPs were smaller than 250 nm, with a spherical pattern and acceptable uniformity with a zeta potential around +20 mV. The loading efficacy was about 85%, and most of the loaded MTO released at a pH of 5.5 after 48 h with a swelling-controlled mechanism. The NPs showed a relatively lower IC50 than the free MTO, and the BPA-targeted NPs have lower IC50 and better cellular uptake than non-targeted NPs in U87MG cells. More studies on this promising formula are on the way, and the results will be published soon.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据